Abiomed Inc. (ABMD): Price and Financial Metrics


Abiomed Inc. (ABMD): $254.56

7.05 (+2.85%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ABMD POWR Grades


  • ABMD scores best on the Quality dimension, with a Quality rank ahead of 94% of US stocks.
  • The strongest trend for ABMD is in Stability, which has been heading down over the past 179 days.
  • ABMD's current lowest rank is in the Value metric (where it is better than 19.01% of US stocks).

ABMD Stock Summary

  • Abiomed Inc's stock had its IPO on July 30, 1987, making it an older stock than 91.66% of US equities in our set.
  • With a price/earnings ratio of 113.42, Abiomed Inc P/E ratio is greater than that of about 94.43% of stocks in our set with positive earnings.
  • The ratio of debt to operating expenses for Abiomed Inc is higher than it is for about merely 0.5% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Abiomed Inc are JAZZ, CMTL, SCOR, BCOV, and SNES.
  • Visit ABMD's SEC page to see the company's official filings. To visit the company's web site, go to www.abiomed.com.

ABMD Valuation Summary

  • In comparison to the median Healthcare stock, ABMD's price/sales ratio is 365.79% higher, now standing at 17.7.
  • Over the past 243 months, ABMD's price/earnings ratio has gone up 128.3.
  • ABMD's price/sales ratio has moved up 4.3 over the prior 243 months.

Below are key valuation metrics over time for ABMD.

Stock Date P/S P/B P/E EV/EBIT
ABMD 2021-08-31 17.7 12.6 107.0 75.0
ABMD 2021-08-30 17.5 12.5 106.1 74.4
ABMD 2021-08-27 17.4 12.4 105.4 73.9
ABMD 2021-08-26 17.4 12.4 105.4 73.9
ABMD 2021-08-25 17.4 12.4 105.2 73.8
ABMD 2021-08-24 17.4 12.4 105.1 73.7

ABMD Growth Metrics

    The 2 year net income to common stockholders growth rate now stands at 80.98%.
  • The 3 year cash and equivalents growth rate now stands at 150.92%.
  • The year over year revenue growth rate now stands at 0.79%.
Over the past 70 months, ABMD's revenue has gone up $673,605,000.

The table below shows ABMD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 1,003.148 292.893 133.036
2021-09-30 973.635 281.541 149.152
2021-06-30 935.257 298.178 154.412
2021-03-31 847.522 274.578 225.525
2020-12-31 812.935 274.696 200.467
2020-09-30 802.856 285.001 207.816

ABMD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ABMD has a Quality Grade of A, ranking ahead of 96.73% of graded US stocks.
  • ABMD's asset turnover comes in at 0.659 -- ranking 58th of 186 Medical Equipment stocks.
  • INGN, KIDS, and ATRC are the stocks whose asset turnover ratios are most correlated with ABMD.

The table below shows ABMD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.659 0.819 0.206
2021-06-30 0.655 0.817 0.217
2021-03-31 0.616 0.809 0.303
2020-12-31 0.623 0.809 0.278
2020-09-30 0.643 0.808 0.303
2020-06-30 0.667 0.812 0.248

ABMD Price Target

For more insight on analysts targets of ABMD, see our ABMD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $387.33 Average Broker Recommendation 1.65 (Moderate Buy)

ABMD Stock Price Chart Interactive Chart >

Price chart for ABMD

ABMD Price/Volume Stats

Current price $254.56 52-week high $379.30
Prev. close $247.51 52-week low $219.85
Day low $244.66 Volume 218,300
Day high $254.82 Avg. volume 350,993
50-day MA $257.84 Dividend yield N/A
200-day MA $307.37 Market Cap 11.61B

Abiomed Inc. (ABMD) Company Bio


Abiomed Inc. develops, and sells medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. The company was founded in 1981 and is based in Danvers, Massachusetts.


ABMD Latest News Stream


Event/Time News Detail
Loading, please wait...

ABMD Latest Social Stream


Loading social stream, please wait...

View Full ABMD Social Stream

Latest ABMD News From Around the Web

Below are the latest news stories about Abiomed Inc that investors may wish to consider to help them evaluate ABMD as an investment opportunity.

Riding The Stock Waves: Update On The Medical Devices Sector

For the Stock Waves webinar on February 10, we wanted to focus on medical devices sector using the iShares U.S. Medical Devices ETF (IHI). IHI is looking pretty convincing so far with this bounce off of the January low that a bottom has been struck. That low was the 38.2%...

Stock Waves on Seeking Alpha | February 21, 2022

Here's Why You Should Retain Abiomed (ABMD) Stock For Now

Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line.

Yahoo | February 11, 2022

Abiomed to Present at the SVB Leerink 11th Annual Global Healthcare Conference

DANVERS, Mass., February 08, 2022--Abiomed to present at the SVB Leerink 11th Annual Global Healthcare conference.

Yahoo | February 8, 2022

Abiomed Inc. (ABMD) CEO Mike Minogue on Q3 2022 Results - Earnings Call Transcript

Abiomed, Inc. (ABMD) Q3 2022 Earnings Conference Call February 03, 2022, 08:00 AM ET Company Participants Nicole Nath - Manager, Investor Relations Mike Minogue - Chairman, President and Chief Executive Officer Todd Trapp - Vice President and Chief Financial Officer Conference Call Participants Chris Cooley - Stephens Chris Pasquale -...

SA Transcripts on Seeking Alpha | February 4, 2022

BTIG Reaffirms Their Hold Rating on Abiomed (ABMD)

E ratio of 94.72.

Howard Kim on TipRanks | February 3, 2022

Read More 'ABMD' Stories Here

ABMD Price Returns

1-mo -2.93%
3-mo -21.11%
6-mo -24.73%
1-year -19.70%
3-year -2.64%
5-year 78.79%
YTD -29.13%
2021 10.79%
2020 90.05%
2019 -47.52%
2018 73.44%
2017 66.32%

Continue Researching ABMD

Here are a few links from around the web to help you further your research on Abiomed Inc's stock as an investment opportunity:

Abiomed Inc (ABMD) Stock Price | Nasdaq
Abiomed Inc (ABMD) Stock Quote, History and News - Yahoo Finance
Abiomed Inc (ABMD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6101 seconds.